Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

26 young people with type 1 diabetes successfully surmount 13,000 feet in 'India's 2nd T1D Challenge 2018'

Posted On: 2018-09-19 11:24:03

Twenty six young Indians with type 1 diabetes (T1D) surmounted the breathtaking Chandrakhani Pass at 13,000 ft. in the Himalayas, proving that anyone with this disease can pursue challenges that otherwise seem impossible. With last year's success of the first T1D Challenge held in Maharashtra (at 5400 ft.), Sanofi India along with Diabetes India stepped up the initiative with a bigger challenge this year with 'India's 2nd T1D Challenge 2018 - OneUp Trek'.

Young trekkers aged 15 to 30 years from 16 cities across India, participated in this challenge to bring type 1 diabetes to the fore, and bust myths about the disease.

N. Rajaram, Managing Director, Sanofi India said, "India accounts for most children with type 1 diabetes within South-East Asia and this number increases by 3-5% every year1. Sanofi India introduced the 'OneUp Trek' to empower children with type 1 diabetes and give them the opportunity to explore their potential in an encouraging and supportive environment. We are proud of these young, enthusiastic individuals who have not only shown tremendous courage, but have also exhibited extraordinary discipline and responsibility in effectively managing their diabetes through the trek."

Dr. Banshi Saboo, Diabetologist and Executive Secretary, Diabetes India, said "Coming from diverse backgrounds and different parts of the country, these 26 young trekkers united to establish one fact that 'nothing is impossible'. Their courage and determination in the face of a challenging terrain is commendable and an inspiration to others living with the disease. This trek was also a demonstration of the fact that with the right kind of awareness, preparedness and motivation, people with type 1 diabetes can pursue any challenge. Discipline is the key, which comes with a controlled diet, regular monitoring of blood sugar and timely insulin".

He added, 'It is imperative that we give people living with type 1 diabetes a platform to explore their potential and empower them to live optimally. Sanofi India has rightfully pioneered this initiative and we plan to make this bigger and more meaningful, each year."

An essential part of each participant's trekking gear was a compact diabetes kit containing a glucometer, insulin and syringes or an insulin pen. During the trek, they had to monitor their blood sugar at least seven times a day to make sure it was well controlled. All meals were planned in advance to ensure a balanced mix of protein, carbohydrates and fat.

Talking about his patients, Dr. Banshi Saboo further added, "My patients try to be regular in controlling their diet, monitoring glucose levels and administering insulin. They have shown a lot of discipline and courage in taking on this challenge, and I am very proud of their accomplishments."

Living with type 1 diabetes presents a unique set of challenges and people who are diagnosed with it must learn to adapt a lifestyle of control and regulation. It's a matter of adopting the 'fighting' attitude, if one wants to truly beat this disease.

The young trekkers' who took part in 'OneUp trek' have truly illustrated that with a wellcontrolled lifestyle, the right attitude and proper disease management, it is possible to take on any challenge and achieve every dream.

1 K.M Prasanna et al 'Consensus statement on diabetes in children 2014 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056121/

Shares of Sanofi India Ltd was last trading in BSE at Rs.6362.05 as compared to the previous close of Rs. 6525.25. The total number of shares traded during the day was 495 in over 245 trades.

The stock hit an intraday high of Rs. 6597.1 and intraday low of 6362.05. The net turnover during the day was Rs. 3217530.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

V2 Retail Ltd announces resignation of CEO

Dynamic Industries Ltd board to consider divestment of subsidiary

Sonata Software makes Strategic Investment in Retail10X

Karnataka Bank reports Rs. 13.26 crore fraud to RBI

CCL Products India Ltd board declares interim dividend of Rs. 1.75

Sri KPR Industries Ltd board to consider sale of 1.5 MW wind mill unit

Vikas WSP Ltd receives export orders aggregating Rs. 176.84 crore

International Paper APPM Ltd to shut Rajahmundry facility from March 25 to March 30, 2019

Newly launched Domino's Pizza in Bangladesh breaks global record in first week

Sustained water conservation efforts in Suburban Tambaram, Chennai

James Warren Tea Ltd board approves buy back at Rs. 115

Escorts Ltd appoints Mr. Shailendra Agrawal as an Executive Director

EID Parry Ltd to invest Rs. 70 crore in subsidiary

Infosys to enter into agreement with The House Fund II, L P

US FDA completes audit of R&D facility of Aurigene Discovery Technologies Ltd

Jindal Stainless Park Ltd becomes subsidiary of Jindal Stainless Ltd

Raghav Productivity Enhancers bestowed with 'SME - Empowering India Awards 2019'

Tejas Networks appoints two new board of directors

Kallam Textiles Ltd calls for rights issue committee meeting on March 27, 2019

Tata Steel Bsl Ltd allots OCRPS worth Rs. 6700 crore to Tata Steel

Galaxy Surfactants Ltd board to consider interim dividend on March 29, 2019

ICRA reaffirms rating of Deepak Nitrite Ltd

Bharat Gears Ltd board fixes April 3, 2019 as record date for rights issue

Amber Enterprises India Ltd to acquires 80% in Sidwal Refigeration Industries Pvt Ltd

Sukhjit Starch & Chemicals Ltd board to consider allotment of bonus shares on March 30, 2019

EID Parry Ltd declares second interim dividend of Rs. 1

Alkem Laboratories Ltd update on US FDA Inspection at its facility located at St. Louis, USA

Mac Hotels Ltd calls for board meeting on March 29, 2019

Cadila's Pharmaceutical Technology Centre successfully completes USFDA inspection

Zydus receives final approval from the USFDA for Lurasidone Hydrochloride Tablets

Aurionpro wins prestigious order from a leading bank in Singapore

Steelco Gujarat Ltd updates on loan agreement with Costronal Holdings SA

Caplin Steriles gets USFDA approval for Glycopyrrolate Injection

Lupin launches generic Levothyroxine Sodium Tablets USP

Barclays and TCS partner to Help Children with Locomotor Disabilities

Mahindra World City, Jaipur launches eco-friendly bicycle sharing services

GVK Group stake in Mumbai Airport to increase to 74%

Tata Power SED bags Rs 1,200 crore contract from the Ministry of Defence

Woodsvilla Ltd fixes record date for sub-division of equity shares

Alembic Pharma receives USFDA Approval for Azelastine Hydrochloride Ophthalmic Solution, 0.05%

PVR Cinemas launches its 10th multiplex in Telangana

Garden Reach Shipbuilders & Engineers Ltd board to consider interim dividend on March 24, 2019

Jubilant Life Sciences Ltd updates on USFDA inspection at API facility, Nanjangud

MeDirect Bank Belgium, the Online Only Bank, Extends its Product Offerings with Infosys Finacle

Hansard Global Plc Selects SaaS-Based Majesco LifePlus Solutions to Transform their Business

ENIL commences radio station at Asansol

Mac Charles India Ltd seeks shareholders approval for related party transactions

1st Foundation Day of ICT-IOC

Infosys Ltd board to consider Q4, FY19 results on April 11 - 12, 2019

Syngene International wins CMO Leadership Awards presented by Life Science Leader Magazine







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019